What are the opening hours?

Monday 8am - 5:30pm Tuesday 8am - 5:30pm Wednesday 8am - 5:30pm Thursday 8am - 5:30pm Friday 8am - 5pm

OralDNA Labs

Our mission is to help healthcare providers treat, heal, and inspire oral health through salivary dia Can help guide therapy based on causation and genetics.

OralDNA® Labs is a leader in advancing wellness through salivary diagnostics. The company’s goal is to help the medical and dental professionals in all healthcare settings achieve better clinical outcomes by providing reliable, definitive, and cost-effective clinical tests that drive the detection and prognosis of disease at an earlier, more treatable stage. Innovative salivary diagnostic tests from OralDNA® Labs are fundamental elements of a patient’s wellness plan. OralDNA® currently offers several DNA polymerase chain reaction (PCR) & next-generation sequencing tests:

The Alert 2™ (MyPerioPath® + MyPerioID® IL-6) Identifies one gene marker, IL-6, in combination with the type and concentration of perio-pathogenic bacteria. The MyPerioPath® identifies and measures 11 specific bacteria that are known to significantly contribute to periodontal disease. The MyPerioID® determines whether a patient is susceptible to exaggerated inflammatory responses which may increase the risk and severity of periodontal disease. Celsus One™ evaluates 8 genes associated with increased risk and severity of periodontal disease, diabetes, cardiovascular disease, and rheumatoid diseases. The OraRisk HPV (Human papillomavirus) test, detects all HPV type(s) that may be present in the oral cavity. Test report provides information about types that may be associated with an increased risk of oral cancer. OraRisk® HSV assists in accurately identifying oral vesicles, ulcers and other forms of painful oral and throat lesions caused by herpes simplex virus types 1 & 2. OraRisk® Candida identifies all common species of the yeast, Candida; which is known to cause oral thrush in patients with a normal or compromised immune system.

01/16/2026

This Week on Trends in Salivary Testing: "RDH Spotlight: Mohini Patel"

"By utilizing salivary diagnostics, patients can take an active role in their oral health through co-diagnosis, which in turn improves their compliance with recommended care."

Read Now: https://www.oraldna.com/trends-in-salivary-testing/index.php/2026/01/16/rdh-spotlight-mohini-patel/

01/12/2026

"With integrated records, dentists can tailor treatments to minimize risk and support whole-person health."

At OralDNA, we are proud to integrate with Epic and support PDS Health, enabling integrated health care.

Read Now: https://www.epic.com/epic/post/for-patients-shared-medical-records-enable-safer-dental-visits/

01/09/2026

This Week on Trends in Salivary Testing: "Unexplained Infertility, Explained?" by Dr. Neusha Najafi

"'Unexplained infertility' may not reflect true idiopathy, but rather diagnostic blind spots, particularly at the intersection of oral health, systemic inflammation, and shared microbial exposure."

Read now: https://www.oraldna.com/trends-in-salivary-testing/index.php/2026/01/09/unexplained-infertility-explained/

01/06/2026

January's edition of the OralDNA Café Newsletter is here!

Read now: https://mailchi.mp/oraldna/january-2026-newsletter

01/05/2026

Did you know that your oral health is directly connected to your overall wellness?

A recent study found an associated with multiple sclerosis and the oral microbiome.

"Together, these findings suggest that oral microbial and metabolic changes may contribute to inflammation and disease processes in MS (multiple sclerosis)."

Read now: https://pathology.medicine.uiowa.edu/news/2025/10/ui-study-links-multiple-sclerosis-unique-oral-microbiome

01/02/2026

An updated MyPerioPath® Antibiotics Guide is now in effect following our most recent clinical review. These periodic reviews are an essential part of our commitment to evidence-based care, ensuring the recommendations outlined in the report reflect the most current evidence and published literature.

Read now to learn more: https://www.oraldna.com/trends-in-salivary-testing/index.php/2026/01/02/update-to-myperiopath-antibiotic-options-what-you-need-to-know

01/01/2026

Happy New Year from the OralDNA Labs Team!

Wishing you and your team a year filled with health, happiness, and bright smiles. ✨

#2026

12/29/2025

Did you know? Studies continue to highlight the role of oral health on cardiovascular health.

A new American Heart Association scientific statement details how oral health may affect cardiovascular outcomes and highlights how prevention and treatment of gum disease may reduce risk of cardiovascular disease.

"Gum disease may be linked to plaque buildup in arteries, higher risk of major CVD events"

Read now: https://newsroom.heart.org/news/gum-disease-may-be-linked-to-plaque-buildup-in-arteries-higher-risk-of-major-cvd-events

With MyPerioPath® from OralDNA, you can identify the presence and quantity of the pathogenic oral bacteria that cause gum disease, enabling more preventive care and personalized treatment planning.

12/26/2025

This Week on Trends in Salivary Testing: "Throwback: Light the Flame of Awareness" by Brittany Hill, RDH

"Through lab testing, the unknown becomes the known."

Read now: https://www.oraldna.com/trends-in-salivary-testing/index.php/2025/12/26/throwback-light-the-flame-of-awareness

12/22/2025

Happy Holidays from the OralDNA Labs Team!

Wishing you and your team a healthy, safe, and happy holiday season. May your oral health sparkle extra bright! ✨

12/19/2025

This Week on Trends in Salivary Testing: "Throwback: How Do You Speak Testing? With Janice Kaeley DDS, MSD"

“Diabetes and gum disease are very intimately linked, and at times we are the first to notice changes in your gums that may point to diabetes.”

Read now: https://www.oraldna.com/trends-in-salivary-testing/index.php/2025/12/19/throwback-how-do-you-speak-testing-with-janice-kaeley-dds-msd

12/15/2025

Did you know? "On average, people with oral health problems are three times more likely to develop systemic diseases."

Read more: https://www.medscape.com/viewarticle/medical-dental-divide-harming-your-patients-2025a1000r4y

By testing with OralDNA, you can identify the presence of pathogenic bacteria in your patients, enabling more preventive, personalized, and collaborative care.

Address

7400 Flying Cloud Drive
Eden Prairie, MN
55344

Opening Hours

Monday	8am - 5:30pm
Tuesday	8am - 5:30pm
Wednesday	8am - 5:30pm
Thursday	8am - 5:30pm
Friday	8am - 5pm

Website

https://linktr.ee/oraldna, https://www.oraldna.com/

Alerts

Be the first to know and let us send you an email when OralDNA Labs posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your practice to be the top-listed Clinic in Eden Prairie?

Our Story

OralDNA® Labs is a leader in advancing wellness through salivary diagnostics. The company’s goal is to help medical and dental professionals in all healthcare settings achieve better clinical outcomes by providing reliable, definitive, and cost-effective clinical tests that drive the detection and prognosis of disease at an earlier, more treatable stage. Innovative salivary diagnostic tests from OralDNA® Labs are fundamental elements of a patient’s wellness plan. OralDNA® currently offers several DNA polymerase chain reaction (PCR) & next-generation sequencing tests: The Alert 2™ (MyPerioPath® + MyPerioID® IL-6) Identifies one gene marker, IL-6, in combination with the type and concentration of perio-pathogenic bacteria. Can help guide therapy based on causation and genetics. The MyPerioPath® identifies and measures 11 specific bacteria that are known to significantly contribute to periodontal disease.

OraRisk® Caries identifies the 3 most common cariogenic pathogens associated with risk of developing bacterial caries. The MyPerioID® determines whether a patient is susceptible to exaggerated inflammatory responses which may increase the risk and severity of periodontal disease. Celsus One™ evaluates 8 genes associated with increased risk and severity of periodontal disease, diabetes, cardiovascular disease, and rheumatoid diseases. The DNA DrugMap™ family of genetic tests aid in personalizing prescription medications and dosing decisions based on an individual’s drug metabolism. The OraRisk HPV (Human papillomavirus) test, detects all HPV type(s) that may be present in the oral cavity. Test report provides information about types that may be associated with an increased risk of oral cancer. OraRisk® HSV assists in accurately identifying oral vesicles, ulcers and other forms of painful oral and throat lesions caused by herpes simplex virus types 1 & 2. OraRisk® Candida identifies all common species of the yeast, Candida; which is known to cause oral thrush in patients with a normal or compromised immune system.